Rekombinanter IL-12, IL-23 (Ustekinumab Biosimilar) Antikörper

Produktnummer ABIN7795099

Der Maus Monoklonal anti-IL-12, IL-23 (Ustekinumab Biosimilar) Antikörper (ABIN7795099) detektiert spezifisch IL-12, IL-23 (Ustekinumab Biosimilar) in FACS und in vivo. Dieser Antikörper reagiert spezifisch mit Proben aus Human.

Kurzübersicht für Rekombinanter IL-12, IL-23 (Ustekinumab Biosimilar) Antikörper (ABIN7795099)

Target: IL-12, IL-23 (Ustekinumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser IL-12, IL-23 (Ustekinumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), In vivo Studies (in vivo)

Güteklasse: Research Grade

Produktdetails anti-IL-12, IL-23 (Ustekinumab Biosimilar) Antikörper

Expressionssystem: Mammalian cells

Verwendungszweck: Ustekinumab Biosimilar, Human IL-12 / IL-23 Monoclonal Antibody

Produktmerkmale: What is Ustekinumab Biosimilar research grade? Ustekinumab is a human anti-IL-12 / IL-23 monoclonal antibody being developed for the treatment of a number of T-cell driven autoimmune diseases. It targets and neutralize interleukin-12 and interleukin-23, two proteins associated with inflammation, such as pro-inflammatory interleukins or tumor necrosis factor- alpha. Ustekinumab represents a novel approach to treating psoriasis, Multiple Sclerosis, Crohn's Disease and other autoimmune and inflammatory disorders. Ustekinumab biosimilar uses the same protein sequences as the therapeutic antibody ustekinumab.

Aufreinigung: Protein A or G affinity column

Reinheit: >95 % by reducing SDS-PAGE

Endotoxin-Niveau: < 1 EU per 1 mg of the protein by the LAL method

Immunogen: Human IL-12 / IL-23

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: > 3 mg/mL

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Details zu IL-12, IL-23 (Ustekinumab Biosimilar)

Target: IL-12, IL-23 (Ustekinumab Biosimilar)

Andere Bezeichnung: Ustekinumab Biosimilar

Substanzklasse: Biosimilar